Figure 2From: The La antigen is over-expressed in lung cancer and is a selective dead cancer cell target for radioimmunotherapy using the La-specific antibody APOMAB®DAB4 binding to dead LL2 cells in vitro . LL2 cells were treated with cisplatin for 48 h and (A) DAB4 binding or (B) Sal5 binding to dead cells was examined by flow cytometry. n = 3.Back to article page